(PTGX) is a Biotechnology company. Protagonist Therapeutics is a clinical-stage biopharmaceutical company that focuses on discovering and developing peptide-based new chemical entities (NCEs) that can potentially transform existing treatment paradigms in disease areas with significant unmet medical needs. Protagonist Therapeutics employs 107 people (+14.4% YoY, +19 people) and has an annual revenue of $209.2M, founded in 2006. Headquartered in Newark, California, United States, with presence in